← Evidence map

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2015

Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?

Katelijne van de Vooren et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2015
2016
2017
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25407841